| 英文名 | [D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P |
|---|---|
| 英文别名 |
H-D-ARG-D-PRO-LYS-PRO-GLN-GLN-D-PHE-PHE-D-HIS-LEU-MET-NH2
Substance P,[D-Arg1,D-Pro2,D-Phe7,D-His9] (D-ARG1,D-PRO2,D-PHE7,D-HIS9)-SUBSTANCE P D-ARG-PRO-LYS-PRO-D-PHE-GLN-D-TRP-PHE-GLY-LEU-D-TRP-NH2 H-D-ARG-PRO-LYS-PRO-D-PHE-GLN-D-TRP-PHE-GLY-LEU-D-TRP-NH2 (D-ARG1,D-PHE5,D-TRP7,11)-SUBSTANCE P D-ARG-D-PRO-LYS-PRO-GLN-GLN-D-PHE-PHE-D-HIS-LEU-MET-NH2 Substance P-[D-Arg1,D-Pro2,D-Phe7,DHis9] |
| 描述 | (D-Arg1、D-Pro2、D-Phe7、D-His9)-P物质是一种选择性NK1受体拮抗剂[1]。 |
|---|---|
| 相关类别 | |
| 靶点 |
NK1 |
| 参考文献 |
| 分子式 | C67H102N20O13S |
|---|---|
| 分子量 | 1427.72000 |
| 精确质量 | 1426.77000 |
| PSA | 570.61000 |
| LogP | 4.52850 |
| WGK德国 | 3 |
|---|